四妙散加味联合左卡尼汀治疗少、弱精症疗效观察
开篇：润墨网以专业的文秘视角，为您筛选了一篇四妙散加味联合左卡尼汀治疗少、弱精症疗效观察范文，如需获取更多写作素材，在线客服老师一对一协助。欢迎您的阅读与分享！
【摘要】目的：观察中药四妙散加味治疗湿热下注证少、弱精症临床疗效。方法：选取符合标准的42例患者，服用四妙散加味和左卡尼汀口服液联合治疗。结果：42例患者治疗后痊愈16例，显效18例，有效4例，无效4例，总有效率为90.48%。治疗4周后自身前后对照量、活动率、密度、（a+b）级含量差异均无统计学意义（P>0.05）；治疗8周后差异具有统计学意义（P
【关键词】四妙散；湿热下注证；少、弱精症
【Abstract】Objectives： To observe the clinical curative effect of traditional Chinese medicine （TCM） Simiaosan jiawei in treating asthenozoospermia. Methods： 42 patients meeting the criterion were selected and treated with Simiaosan jiawei combined with l-carnitine. Results： According to the results of 42 patients， there were 16 cured cases after treatment， 18 cases with markedly effect， 4 cases with effective results and 4 invalid cases. The total effective rate was 90.48%. The differences in semen quantity， activity rate， sperm density， and sperm （grade a + b） content between 4 weeks after treatment and before the treatment had no statistical significance （P> 0.05）. The difference between 8 weeks after treatment and before the treatment was statistically significant （P< 0.05）； The differences between 12 weeks after treatment and before the treatment had statistical significance （P< 0.01）. Conclusion： Simiaosan jiawei combined with l-carnitine has good clinical curative effect in the treatment of asthenozoospermia， which is worthy of further investigation.
【Key words】Simiaosan jiawei； Damp-heat syndrome； Asthenozoospermia
【中图分类号】R277.33【文献标志码】A
据统计我国育龄夫妇中不孕不育患者约占10%，其中男方因素占30%3.41 years old， and the pelvic organ prolapse quantification （POP-Q） stage was III～IV stage. Pre- and post-operative symptoms were assessed using the urinary distress inventory （UDI-6） and the incontinence impact questionnaire （IIQ-7）， and the international continence society criteria were used for the urodynamic evaluation. Results： Among the total 30 patients， 22 patients underwent partial colpocleisis and another 8 underwent the total colpocleisis. Seven women underwent also a concomitant trans-obturator tension-free （TOT） procedure. Of the patients， 65.7%， 26.8% and 7.5% were ‘very satisfied’， ‘satisfied’ and ‘not satisfied’， respectively. After the colpocleisis operations， UDI-6 and IIQ-7 scores were improved significantly （P>0.05）. Post-operative urinary retention was not observed and prolapse recurred in one patient. Conclusion： Colpocleisis is a safe and effective surgical technique in treating the pelvic organ prolapse for the elderly female patients， with a high patient satisfaction rate.
[10]Wu JM， Matthews CA， Conover MM， et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstetrics & Gynecology， 2014， 123（6）： 1201-1206.
[11]Kakos AB， Lovejoy DA， Whiteside JL. Quality of information on pelvic organ prolapse on the Internet. International Urogynecology Journal， 2015， 26（4）： 551-555.
[12]Koski ME， Chow D， Bedestani A， et al. Colpocleisis for advanced pelvic organ prolapse. Urology， 2012， 80（3）： 542-546.
[13]Abbasy S， Kenton K. Obliterative procedures for pelvic organ prolapse. Clin Obstet Gynecol， 2010（53）：86-98.
[14]Catanzarite T， Rambachan A， Mueller MG， et al. Risk factors for 30-day perioperative complications after Le Fort colpocleisis. The Journal of Urology， 2014， 192（3）： 788-792.
[15]Abbasy S， Lowenstein L， Pham T， et al. Urinary retention is uncommon after colpocleisis with concomitant mid-urethral sling. Int Urogynecol J， 2009（20）：213-216.
[16]Fitzgerald MP， Richter HE， Bradley CS， et al. Pelvic support， and pelvic symptoms and patient satisfaction after colpocleisis. Int Urogynecol J Pelvic Floor Dysfunct， 2008（19）：1603-1609.
（收稿日期：2015-10-08）